randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als A Multicenter, Randomized, Double-blind, Clinical Efficacy in Patients with Dementia Associated with Cerebrovascular Disease Altered Bioenergetics and Metabolic Homeostasis
Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis ScienceDirect Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet The Scientific and Therapeutic Rationale for OffLabel Treatments in Amyotrophic Lateral Sclerosis Bedlack 2025 Annals of Neurology Wiley Online Library A 1 year multicenter placebo controlled study of acetyl L carnitine in patients with Alzheimer's disease Neurology Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry Full article: Randomized double blind placebo controlled trial of acetyl L carnitine for ALS
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

00262-4/asset/89dd934c-f271-4a89-9f55-b9a4707e82c0/main.assets/gr3_lrg.jpg)



